BCP Partnering Portal / Alfa Cytology
More Information on 'Alfa Cytology'
Alfa Cytology - Channel Partner based in United States of America
Ovarian Cancer Preclinical R&D, also known as Alfa Cytology, is a company that specializes in preclinical research solutions for ovarian cancer therapy development. The company offers a range of services, including cancer modeling, cell line development, and drug discovery. They provide various types of cancer models, such as 2D and 3D tumor models, patient-derived cell lines, and xenograft models, to support cancer research and drug development. Additionally, they offer services for target identification, drug delivery system development, and preclinical research, including efficacy evaluation, DMPK/ADME, and safety assessment. The company's goal is to support researchers and pharmaceutical companies in advancing cancer research and therapeutic development.
Industries:
Pharma & Biotech
Verified Member
The BCP Partnering Portal
Where Manufacturers and Channel Partners / Distributors find each other!
- The BCP Partnering Portal is a specialized matchmaking platform featuring around 28,000 company profiles, who supply products and services within scientific fields. It serves as a crucial resource for facilitating B2B partnerships between manufacturers and channel partners.
- Developed by BioChannel Partners Ltd, an award-winning B2B partnering company with over 22 years of expertise in connecting manufacturers and channel partners of scientific products, the portal ensures that company profiles are kept up-to-date by both the BCP team and verified profile owners.
- This continuous update process ensures that users have access to accurate and current information, enhancing the platform's effectiveness in fostering successful business collaborations.
- Take advantage of this resource and join to manage your own company profile and search for new partners.
Opens Keyword Search with this company's main keywords and company type already chosen, leaving the company itself out. Add or remove choices to widen or narrow the list; Premium members, then the companies that share the most keywords, are listed first.